There is increasing evidence between aberrant glycosylations or expression of mucin peptides and neoplasms, such as MUC1, MUC2, MUC5AC in pancreatic neoplasm; MUC1, MUC4 in Gastrointestinal neoplasms [6]. This evidence concerns the gene MUC5AC and digestive system neoplasm.